A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Enzon Pharmaceuticals, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Enzon Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00931840
First received: June 30, 2009
Last updated: September 19, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2012
  Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)